anmelden
SPI
20.270,57
PKT
+7,35
PKT
+0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.07.12 | Clariant buy | Nomura | |
| 16.07.12 | Givaudan reduce | Nomura | |
| 16.07.12 | ABB (Asea Brown Boveri) buy | Citigroup Corp. | |
| 16.07.12 | Swisscom buy | Deutsche Bank AG | |
| 16.07.12 | Kühne + Nagel International neutral | Sarasin Research | |
| 16.07.12 | UBS underperform | Exane-BNP Paribas SA | |
| 16.07.12 | Julius Bär buy | Sarasin Research | |
| 16.07.12 | Kühne + Nagel International hold | Vontobel Research | |
| 16.07.12 | Swatch (I) buy | Vontobel Research | |
| 16.07.12 | EMS-CHEMIE hold | Vontobel Research | |
| 16.07.12 | UBS outperform | Keefe, Bruyette & Woods, Inc. | |
| 13.07.12 | BB Biotech kaufen | Independent Research GmbH | |
| 13.07.12 | Swiss Re underperform | Banc of America Securities-Merrill Lynch | |
| 13.07.12 | Novartis buy | Nomura | |
| 13.07.12 | EMS-CHEMIE buy | Sarasin Research | |
| 13.07.12 | Novartis kaufen | Fuchsbriefe | |
| 13.07.12 | Kudelski sell | UBS AG | |
| 13.07.12 | UBS outperform | Credit Suisse Group | |
| 13.07.12 | EMS-CHEMIE hold | Vontobel Research | |
| 13.07.12 | Sika hold | Vontobel Research | |
| 13.07.12 | UBS outperform | Macquarie Research | |
| 12.07.12 | Holcim hold | Deutsche Bank AG | |
| 12.07.12 | Roche neutral | J.P. Morgan Cazenove | |
| 12.07.12 | Swatch (I) buy | Deutsche Bank AG | |
| 12.07.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 12.07.12 | Holcim hold | Deutsche Bank AG | |
| 12.07.12 | Clariant neutral | HSBC | |
| 12.07.12 | Kühne + Nagel International neutral | UBS AG | |
| 12.07.12 | Novartis outperform | Credit Suisse Group | |
| 12.07.12 | Partners Group hold | Vontobel Research | |
| 12.07.12 | Temenos neutral | UBS AG | |
| 12.07.12 | Helvetia Baloise neutral | Sarasin Research | |
| 12.07.12 | Zurich Insurance buy | Sarasin Research | |
| 12.07.12 | Partners Group neutral | Sarasin Research | |
| 12.07.12 | Temenos buy | Vontobel Research | |
| 12.07.12 | Dätwyler hold | Vontobel Research | |
| 12.07.12 | Novartis hold | Vontobel Research | |
| 12.07.12 | Novartis neutral | Citigroup Corp. | |
| 11.07.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 11.07.12 | Logitech outperform | Exane-BNP Paribas SA |
